VSIG1-MID2 Fusion FISH Probe
The VSIG1-MID2 Fusion FISH Probe is used to confirm a fusion of the VSIG1 and MID2 genes. The fusion of the VSIG1 and MID2 genes has been associated with Prostate Adenocarcinoma, Pancreatic Adenocarcinoma, and Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| VSIG1-MID2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| VSIG1-MID2-20-AQAQ | 20 (40 μL) | 200 μL |
|
MID2 Gene Summary
The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to microtubular structures in the cytoplasm. Alternate splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
Gene Name: Midline 2
Chromosome: CHRX: 107069083 -107174867
Locus: Xq22.3
VSIG1 Gene Summary
This gene encodes a member of the junctional adhesion molecule (JAM) family. The encoded protein contains multiple glycosylation sites at the N-terminal region, and multiple phosphorylation sites and glutamic acid/proline (EP) repeats at the C-terminal region. The gene is expressed in normal stomach and testis, as well as in gastric, esophageal and ovarian cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
Gene Name: V-set And Immunoglobulin Domain Containing 1
Chromosome: CHRX: 107288199 -107322414
Locus: Xq22.3
Gene Diseases
The VSIG1 MID2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
| Pancreatic Adenocarcinoma |
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|